Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ASTON/LMCG Small Cap Growth Fund Class N (ACWDX)

13.16
Net Asset Value
0.00%
1 Day
-7.32%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
1.54%
Expense Ratio
High
Morningstar Risk Rating™
Investment Objective The investment seeks to provide long-term capital appreciation. Under normal circumstances, the fund invests at least 80% of its assets in common stocks and other equity securities of small-cap companies. The managers define a small-cap company as one with a market capitalization below $5 billion at the time of acquisition. The subadviser seeks to achieve above average risk-adjusted returns by identifying unrecognized growth potential.

Performance

1 month+0.92% 3 years+3.72%
3 months+4.77% 5 years+12.37%
1 year-10.38% Since inception+9.61%
Data through --

Peer Comparisonvs. Small growth

 ACWDXCategory
Performance 5-yr return+12.37%+7.26%
Expense ratio1.54%1.33%
Risk 5 year sharpe ratio0.490.61
Net assets$145.4M$849.2M
Average market cap$2.4B$3.0B
Average P/E29.826.1
Portfolio turnover79%79%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyAston
Fund manager & tenureAndrew Morey / 5 Years
Minimal initial investment$2,000.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock95.98%
International stock3.74%
Cash0.28%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 17.31%
Consumer goods 13.43%
Business service 13.17%
Telecommunication 9.39%
Consumer service 7.57%
Top 10 Holdings
Portfolio weighting
SNCR Synchronoss Technologies Inc5.21%
NXST Nexstar Broadcasting Group Inc5.02%
HLS HealthSouth Corp4.56%
CASY Caseys General Stores Inc3.11%
MSCC Microsemi Corp2.81%
SONC Sonic Corp2.77%
SUM Summit Materials Inc2.70%
CAVM Cavium Inc2.68%
SSNC SS&C Technologies Holdings Inc2.68%
NBIX Neurocrine Biosciences Inc2.58%

Partner Offers